Skip to main content
Tech.euFundingExplorerBeta

Epidarex Capital

Investor profile

Epidarex Capital has backed 8 European tech companies across 9 funding rounds between 2015 and 2026, joining rounds totalling €141M. Most active in Healthtech. Data as of Nov 2026.

Deals
9
distinct rounds
Companies
8
backed
Active span
2015–2026
12 yrs
Total round €
€141M
sum of rounds joined

Deals by year

distinct rounds / year
Epidarex Capital — deals by year — interactive chart.
Data table
Epidarex Capital — deals by year
20151
20161
20214
20221
20241
20261

Top sectors

by deals
Epidarex Capital — top sectors — interactive chart.
Data table
Epidarex Capital — top sectors
Healthtech9

Stages

by deals
Epidarex Capital — stages — interactive chart.
Data table
Epidarex Capital — stages
Series A4
Series B3
Other1
Seed1

Countries

by deals
Epidarex Capital — countries — interactive chart.
Data table
Epidarex Capital — countries
UK8
Germany1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Epidarex Capital — 9 dealsEpidarex CapitalScottish Investment Bank - Scottish Enterprise — 2 shared deals · click to openScottish Investment Bank - Scottish EnterpriseSofinnova Partners — 2 shared deals · click to openSofinnova Partners2Invest — 1 shared deals · click to open2InvestBioGeneration Ventures — 1 shared deals · click to openBioGeneration VenturesBioMedPartners — 1 shared deals · click to openBioMedPartnersBoehringer Ingelheim Venture Fund — 1 shared deals · click to openBoehringer Ingelheim Venture FundCaribou Property Limited — 1 shared deals · click to openCaribou Property LimitedDementia Discovery Fund (DDF) — 1 shared deals · click to openDementia Discovery Fund (DDF)EMBL Ventures — 1 shared deals · click to openEMBL VenturesEvotec — 1 shared deals · click to openEvotecForbion — 1 shared deals · click to openForbionFuture Fund — 1 shared deals · click to openFuture FundGIMV — 1 shared deals · click to openGIMVIP Group — 1 shared deals · click to openIP GroupMary Canning — 1 shared deals · click to openMary CanningNovartis Venture Fund — 1 shared deals · click to openNovartis Venture FundPanakès Partners — 1 shared deals · click to openPanakès PartnersRoche Venture Fund — 1 shared deals · click to openRoche Venture Fund

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Frequent co-investors

shared rounds

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
MironidUK2€46M
Enterprise TherapeuticsUK1€30M
Topas TherapeuticsGermany1€18M
Transine TherapeuticsUK1€16M
Leucid BioUK1€14M
Caldan TherapeuticsUK1€6.3M
TheolyticsUK1€5.5M
MacomicsUK1€5.0M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Enterprise TherapeuticsSeries B€30M2024-01
Topas TherapeuticsSeries B€18M2021-07
Transine TherapeuticsSeed€16M2022-06
Leucid BioSeries A€14M2021-10
Caldan TherapeuticsSeries A€6.3M2015-11
MironidSeries A€6.0M2016-06
TheolyticsSeries A€5.5M2021-01
MacomicsOther€5.0M2021-07
← Back to investors